ResearchMoz

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Research In China
Published Date » 2013-11-29
No. Of Pages » 65
   
 Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese preparations have grown year by year. In 2006-2012, China’s injection output presented the CAGR of 19.2%. However, due to the low barriers to entry, China has seen some signs of the surplus injection capacity, which exceeds the demand by roughly 40%. 
   
 Overcapacity and fierce competition are caused by the irrational injection product structure and homogeneity. For example, the output and sales volume of fluid balance injection products with low added value account for 89% of the injection market, but the sales revenue only shares 47%. At the same time, the market demand for...
TABLE OF CONTENT

1 Overview of LVP
1.1 Definition and Classification
1.2 Industry Chain

2 Overview of China LVP Industry Development
2.1 Status Quo
2.2 Competition Pattern
2.3 Product Structure
2.4 Regional Distribution
2. 5 Development Forecast 

3 Chinese LVP Market Segments
3.1 Injection for Fluid Balance
3.2 Therapeutic Injection
3.3 Nutritious Injection
3.3.1 Fructose Injection
3.3.2 Amino Acid Injection
3.3.3 Fat Emulsion Injection
3.4 Injection for Blood Volume Expansion 
3.4.1 Dextran Injection
3.4.2 Hydroxyethyl Starch Injection
3.5 Peritoneal Dialysis Solution

4 Main Companies
4.1 Kelun Pharma 
4.1.1 Profile 
4.1.2 Operation 
4.1.3 Revenue Structure 
4.1.4 Gross Margin 
4.1.5 Clients and Suppliers 
4.1.6 R & D and Investment
4.1.7 LVP Business 
4.1.8 Development Forecast 
4.2 China Resources Double-Crane 
4.2.1 Profile 
4.2.2 Operation 
4.2.3 Revenue Structure 
4.2.4 Gross Margin 
4.2.5 Major Clients 
4.2.6 LVP Business 
4.2.7 Development Forecast 
4.3 Fengyuan Pharmaceutical  
4.3.1 Profile 
4.3.2 Operation 
4.3.3 Revenue Structure 
4.3.4 Gross Margin 
4.3.5 Clients and Suppliers 
4.3.6 LVP Business 
4.3.7 Development Forecast 
4.4 Huaren Pharmaceutical
4.4.1 Profile 
4.4.2 Operation 
4.4.3 Revenue Structure 
4.4.4 Gross Margin 
4.4.5 Clients and Suppliers 
4.4.6 R & D and Investment
4.4.7 Development Forecast 
4.5 Southwest Pharmaceutical 
4.5.1 Profile 
4.5.2 Operation 
4.5.3 Revenue Structure 
4.5.4 Gross Margin 
4.5.5 Major Clients 
4.5.6 LVP Business 
4.5.7 Development Forecast 
4.6 Lijun International Pharmaceutical (Holding)
4.6.1 Profile
4.6.2 Operation 
4.6.3 Shijiazhuang No.4 Pharmaceutical 
4.7 Other Companies
4.7.1 Qingzhou Yaowang Medicine 
4.7.2 Jilin Dubang Pharmaceutical 
4.7.3 Shandong Lukang Cisen Pharmaceutical  
4.7.4 China Otsuka Pharmaceutical 

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Greece: market of prepared foods, obtained by swelling or roasting of cereals
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the prepared foods, obtained by swelling or roasting of cereals market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the prepared foods, obtained by swelling or roasting of cereals market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the...
Greece: market of apparatus for electric control or distribution of electricity
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the apparatus for electric control or distribution of electricity market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the apparatus for electric control or distribution of electricity market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for...
Point Absorber Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
The point absorber is a wave energy device that could potentially provide ample quantities of power in a relatively small device as compared to other technologies. Although there are strategies and numerous designs for using these devices, mostly they all work in the similar manner. They are small in size as compared to the wave length and have bottom mounted structures. Power conversion takes place in various forms depending on the conformation of the device. Vertical movement of the buoy is used for alternate the compression of fluids in various forms of container. The relative motion...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...
Export market in New Zealand driven by innovative and high-value food products
Jul 29, 2014  
Demand for beverages and high value foods in Asia are driving the food and beverage industry in New Zealand. Also there is high demand for dairy products, seafood, meat and processed foods in the Asian economies which fuel the give an export boost to the economy of New Zealand.  Asia has a rapidly growing market for food which in turn is highly beneficial for New Zealand’s export...
Sony plans revival of PlayStation with network services
Jul 29, 2014  
After a nearly USD 10 billion loss over the last six years, Sony Corp has plans of reviving its consumer electronics hero – the PlayStation. Sony will be repositioning the video game console as a center of streamed network services such as social media, music and movies apart from games. The matter is still in its infancy stage of discussion and the plan is to generate revenue from the...